Form 8-K
Material Company Update
2026-04-06
BIIB filed 8-K — material company event
BIOGEN INC. filed an 8-K with the SEC reporting a material event. Filing excerpt: XBRL Viewer
Latest SEC filings for Biogen Inc. (BIIB) explained in plain English: insider buying and selling (Form 4), proposed insider sales (Form 144), material company events (8-K), and quarterly & annual reports (10-Q / 10-K). Sourced directly from SEC EDGAR.
BIOGEN INC. filed an 8-K with the SEC reporting a material event. Filing excerpt: XBRL Viewer
Godbout Sean (Chief Accounting Officer) filed a Form 4 covering compensation-related activity such as stock awards, option exercises, conversions, or tax withholding. These filings are usually neutral.
BIOGEN INC. filed an 8-K with the SEC reporting a material event. Filing excerpt: XBRL Viewer
BIOGEN INC. filed an 8-K with the SEC reporting a material event. Filing excerpt: XBRL Viewer
Viehbacher Christopher (Director, President and CEO) filed a Form 4 covering compensation-related activity such as stock awards, option exercises, conversions, or tax withholding. These filings are usually neutral.
Singhal Priya (Head of Development) filed a Form 4 covering compensation-related activity such as stock awards, option exercises, conversions, or tax withholding. These filings are usually neutral.
Murphy Nicole, listed as Head of Pharm Ops and Tech at BIOGEN INC., reported an open-market purchase of 3 BIIB shares in a Form 4 filing. Insider buying is often treated as a bullish signal because company insiders are committing their own capital.
Kramer Robin (Chief Financial Officer) filed a Form 4 covering compensation-related activity such as stock awards, option exercises, conversions, or tax withholding. These filings are usually neutral.
Keeney Adam (Head of Corporate Development) filed a Form 4 covering compensation-related activity such as stock awards, option exercises, conversions, or tax withholding. These filings are usually neutral.
Izzar Rachid (Head of Global Product Strat.) filed a Form 4 covering compensation-related activity such as stock awards, option exercises, conversions, or tax withholding. These filings are usually neutral.
Grogan Jane (Head of Research) filed a Form 4 covering compensation-related activity such as stock awards, option exercises, conversions, or tax withholding. These filings are usually neutral.
Gregory Ginger (EVP, Human Resources) filed a Form 4 covering compensation-related activity such as stock awards, option exercises, conversions, or tax withholding. These filings are usually neutral.
Godbout Sean (Chief Accounting Officer) filed a Form 4 covering compensation-related activity such as stock awards, option exercises, conversions, or tax withholding. These filings are usually neutral.
ALEXANDER SUSAN H (EVP Chief Legal Officer) filed a Form 4 covering compensation-related activity such as stock awards, option exercises, conversions, or tax withholding. These filings are usually neutral.
BIOGEN INC. filed an 8-K with the SEC reporting a material event. Filing excerpt: XBRL Viewer